Test description
Testing of genes associated with inherited predisposition to central nervous system tumours in patients with CNS tumours or suggestive clinical or family history.
Test information
BRAoVOTM CNS Gene panel
Used to help provide an accurate diagnosis, help predict future disease risk, allow for early intervention and prevention, and aid in treatment plans.
AIP, APC, CDKN1B, CDKN2A, DICER1, EPCAM, LZTR1, MEN1, MLH1, MSH2, MSH6, NF1, NF2, PMS2, PRKAR1A, PTCH1, PTEN, RB1, SMARCA4, SMARCB1, SMARCE1, SUFU, TP53, TSC1, TSC2, VHL
Massively parallet sequencing
4 -5 weeks
None
$499
Cancer genetics test request form preferred. Standard pathology request form accepted.
Blood x 2
EDTA
2 x Bloods taken at 10 minute intervals. Pre-test genetic counselling required. Patient to provide consent prior to testing.